NO20050091L - Fremgangsmater for fremstilling av fibrinogen - Google Patents

Fremgangsmater for fremstilling av fibrinogen

Info

Publication number
NO20050091L
NO20050091L NO20050091A NO20050091A NO20050091L NO 20050091 L NO20050091 L NO 20050091L NO 20050091 A NO20050091 A NO 20050091A NO 20050091 A NO20050091 A NO 20050091A NO 20050091 L NO20050091 L NO 20050091L
Authority
NO
Norway
Prior art keywords
methods
fibrinogen
preparing fibrinogen
preparing
purification
Prior art date
Application number
NO20050091A
Other languages
English (en)
Inventor
David Evans
Sarah Kingsland
Peter Feldman
Robert Clemmitt
Original Assignee
Nat Blood Authority
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Blood Authority filed Critical Nat Blood Authority
Publication of NO20050091L publication Critical patent/NO20050091L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

Anvendelse av immobilisert metallion-affinitetskromatografi for separering av fibrinogen fra plasminogen, for rensing av fibrinogen og minst ett annet protein, for eksempel plasminogen og for samrensning av fibrinogen og faktor XIII.
NO20050091A 2002-07-10 2005-01-06 Fremgangsmater for fremstilling av fibrinogen NO20050091L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0216001.8A GB0216001D0 (en) 2002-07-10 2002-07-10 Process and composition
PCT/GB2003/002928 WO2004007533A1 (en) 2002-07-10 2003-07-07 Processes for the preparation of fibrinogen

Publications (1)

Publication Number Publication Date
NO20050091L true NO20050091L (no) 2005-04-06

Family

ID=9940203

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20050091A NO20050091L (no) 2002-07-10 2005-01-06 Fremgangsmater for fremstilling av fibrinogen

Country Status (17)

Country Link
US (1) US7816495B2 (no)
EP (1) EP1519944B1 (no)
JP (1) JP4324102B2 (no)
AT (1) ATE449104T1 (no)
AU (1) AU2003244850B2 (no)
BR (1) BRPI0312521B8 (no)
CA (1) CA2491716C (no)
DE (1) DE60330146D1 (no)
DK (1) DK1519944T3 (no)
EC (1) ECSP055584A (no)
ES (1) ES2332780T3 (no)
GB (1) GB0216001D0 (no)
IL (1) IL165988A0 (no)
MX (1) MXPA05000395A (no)
NO (1) NO20050091L (no)
PL (1) PL210616B1 (no)
WO (1) WO2004007533A1 (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004009400A1 (de) 2004-02-24 2005-09-08 Zlb Behring Gmbh Fibrinogen Reinigung
DE102004037805B3 (de) * 2004-08-03 2006-03-23 Zlb Behring Gmbh Verfahren zur Hitzebehandlung fibrinogenhaltiger pharmazeutischer Zubereitungen
EP1784415A2 (en) 2004-08-27 2007-05-16 Novo Nordisk Health Care AG Purification of factor xiii polypeptides from biological materials
WO2006056575A1 (en) * 2004-11-23 2006-06-01 Zymogenetics, Inc. Purification of recombinant human factor xiii
FR2887883B1 (fr) * 2005-06-29 2007-08-31 Lab Francais Du Fractionnement Procede de separation des proteines fibrinogene, facteur xiii et colle biologique d'une fraction plasmatique solubilisee et de preparation de concentres lyophilises desdites proteines
CN101067131B (zh) * 2007-04-30 2011-08-17 华南理工大学 一种利用亲和层析法分离纯化纤溶酶的方法
AU2009240026B2 (en) 2008-04-21 2014-05-29 Novo Nordisk Health Care Ag Dry transglutaminase composition
US8945895B2 (en) 2009-07-31 2015-02-03 Baxter International Inc. Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof
CN106046147B (zh) 2010-09-20 2019-11-19 欧克塔医药公司 纤维蛋白原生产方法
AU2013231321B2 (en) 2012-03-13 2017-05-25 Octapharma Ag Improved process for production of fibrinogen and fibrinogen produced thereby
US9243239B2 (en) 2012-03-26 2016-01-26 The Regents Of The University Of Colorado, A Body Corporate Purification of cystathionine beta-synthase
US20140154233A1 (en) 2012-12-05 2014-06-05 Csl Limited Method of purifying therapeutic proteins
US10188965B2 (en) 2012-12-05 2019-01-29 Csl Behring Gmbh Hydrophobic charge induction chromatographic depletion of a protein from a solution
US9675678B2 (en) 2013-01-29 2017-06-13 The Regents Of The University Of Colorado, A Body Corporate Compositions and methods for treatment of homocystinuria
US9932388B2 (en) 2014-11-13 2018-04-03 Hemarus Therapeutics Limited Chromatographic process for producing high purity fibrinogen and thrombin
NZ741552A (en) 2015-11-09 2022-04-29 Univ Colorado Regents Compositions and methods for treatment of homocystinuria
WO2017112757A1 (en) * 2015-12-23 2017-06-29 Shire Human Genetic Therapies, Inc. Collagen 7 compositions and methods of using the same
CA3059592A1 (en) 2017-04-17 2018-10-25 The Regents Of The University Of Colorado, A Body Corporate Optimization of enzyme replacement therapy for treatment of homocystinuria
WO2022133973A1 (en) 2020-12-25 2022-06-30 Guangzhou Bioseal Biotech Co., Ltd. Fibrinogen aseptic filtration
AU2022327637A1 (en) 2021-08-13 2024-01-18 Biotest Ag Fibrinogen compositions and methods of preparation

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2618784B1 (fr) 1987-07-30 1990-04-06 Lille Transfusion Sanguine Concentre de proteines coagulables par la thrombine, son procede d'obtention et son utilisation a titre de colle biologique
US5445958A (en) * 1987-12-22 1995-08-29 National Blood Authority Process for purifying blood clotting factors
JPH02193913A (ja) * 1989-01-20 1990-07-31 Denki Kagaku Kogyo Kk パイロジエンを除去する方法
US5169936A (en) 1989-04-14 1992-12-08 Biogen, Inc. Protein purification on immobilized metal affinity resins effected by elution using a weak ligand
US5792835A (en) * 1991-09-05 1998-08-11 Baxter International Inc. Method of preparing a topical fibrinogen complex
WO1994002183A1 (en) 1992-07-27 1994-02-03 Haemacure Biotech Inc. Biocompatible surgical implant
JPH06138127A (ja) 1992-10-26 1994-05-20 Tanabe Seiyaku Co Ltd 標識フィブリノーゲンおよびその用途
US5395923A (en) 1993-02-23 1995-03-07 Haemacure-Biotech, Inc. Process for the obtention of a biological adhesive made of concentrated coagulation factors by "salting-out"
CA2162997A1 (en) 1994-03-18 1995-09-28 Daphne C. Tse Topical fibrinogen complex
JPH0812586A (ja) * 1994-07-01 1996-01-16 Mikimoto Pharmaceut Co Ltd 抗プラスミン剤
GB9424732D0 (en) 1994-12-08 1995-02-08 Common Services Agency Heat treated blood plasma proteins
JPH08333387A (ja) * 1995-06-12 1996-12-17 Mitsubishi Materials Corp タンパク質分離精製方法
US6268487B1 (en) * 1996-05-13 2001-07-31 Genzyme Transgenics Corporation Purification of biologically active peptides from milk
GB9722131D0 (en) 1997-10-20 1997-12-17 Medical Res Council Method
US5981254A (en) 1997-10-30 1999-11-09 Haemacure Corporation Process for producing thrombin from plasma
AUPP521298A0 (en) 1998-08-12 1998-09-03 Life Therapeutics Limited Purification of fibrinogen
JP2001270900A (ja) 2000-03-23 2001-10-02 Nihon Pharmaceutical Co Ltd フィブリノゲンのウイルス不活化法

Also Published As

Publication number Publication date
PL210616B1 (pl) 2012-02-29
BRPI0312521B8 (pt) 2021-05-25
CA2491716A1 (en) 2004-01-22
AU2003244850A1 (en) 2004-02-02
JP2006505508A (ja) 2006-02-16
BRPI0312521B1 (pt) 2019-06-25
IL165988A0 (en) 2006-01-15
ATE449104T1 (de) 2009-12-15
GB0216001D0 (en) 2002-08-21
DE60330146D1 (de) 2009-12-31
MXPA05000395A (es) 2005-09-30
WO2004007533A1 (en) 2004-01-22
EP1519944B1 (en) 2009-11-18
JP4324102B2 (ja) 2009-09-02
PL374080A1 (en) 2005-09-19
BR0312521A (pt) 2005-04-19
EP1519944A1 (en) 2005-04-06
AU2003244850B2 (en) 2009-06-25
US7816495B2 (en) 2010-10-19
US20070042944A1 (en) 2007-02-22
DK1519944T3 (da) 2010-03-29
ES2332780T3 (es) 2010-02-12
CA2491716C (en) 2012-02-07
ECSP055584A (es) 2005-07-06

Similar Documents

Publication Publication Date Title
NO20050091L (no) Fremgangsmater for fremstilling av fibrinogen
NO20091976L (no) Nye forbindelser
DE60107687D1 (de) Cyclpentanoindole, mischungen derartige verbindungen enthaltend und behandlungsmethoden
BRPI0414599A (pt) pirrol-indóis substituìdos
ATE304358T1 (de) (s,s)-reboxetin zur behandlung von migränekopfschmerzen
MXPA03010134A (es) Derivados de ciclohexan-1-4-diamina sustituidos.
ATE541857T1 (de) Optimierte fc-varianten und herstellungsverfahren dafür
MXPA02004666A (es) Gelatinas recombinantes.
YU9404A (sh) Multimerna, usmerena kontrastna sredstva na bazi peptida
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
MXPA05013553A (es) Pirrolodihidroisoquinolinas como inhibidores de pde10.
DK1668001T3 (da) Substituerede heteroarylbenzofuransyrer
NO20063196L (no) Nye fusjonerte pyrrolokarbazoler
NO20055741D0 (no) Nye kjemiske forbindelser
DK1083903T3 (da) Brobundne indenopyrrolocarbazoler
CY1105275T1 (el) Ενωσεις υποκατεστημενης γ-λακτονης ως ανταγωνισται - νμda
GB0216002D0 (en) Process and composition
ATE549024T1 (de) Chinazolin-kaliumkanalhemmer
TR200402030T4 (tr) İkame edilen I-aminobutan-3-ol-türevleri
DE50205466D1 (de) Substituierte 2,5-diamidoindole als ece-inhibitoren zur behandlung von kardiovaskulären erkrankungen
DE60316128D1 (de) N-sulfonylurea-apoptosis-förderer
MXPA04004090A (es) Compuestos substituidos de 1h-quinolin-2-ona.
TW200510323A (en) Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives
MXPA04000272A (es) Derivados de 4-aminociclohexanol sustituidos.
CO5150221A1 (es) Nuevas 3-fenoxi- y 3-fenilalquiloxi-2-fenil-propilaminas sustituidas